Starting Monday, thousands of pharmaceutical industry executives, investors, bankers, and analysts will swarm into San Francisco for the J.P. Morgan Healthcare Conference.
Now in its 37th year, the conference has ballooned from a small event with 150 attendees that was essentially the " birth of biotech," to an event attended by everyone from the biggest pharma company to the smallest biotech. JPMorgan said more than 485 companies are scheduled to present this year.
It's a spot for these companies to meet with investors and each other, and can be the starting point for takeovers or other deals.
